DeuterOncology

Geel, Belgium

DeuterOncology is a preclinical-stage biotech company.

Jan 2023

Series A

Biotechnology Medical Oncology

Top Investors

Newton BiocapitalInvestsudMeusinvest (Noshaq)

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about DeuterOncology

Who are DeuterOncology's investors?

DeuterOncology's investors include Newton Biocapital, Investsud, Meusinvest (Noshaq).

Where is DeuterOncology headquartered?

DeuterOncology is headquartered in Geel, Belgium.

What does DeuterOncology do?

DeuterOncology is a preclinical-stage biotech company.

What stage is DeuterOncology at?

DeuterOncology is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 19, 2023.

MLA

"DeuterOncology — Funding & Investors." VCBacked, January 19, 2023, https://www.vcbacked.co/company/deuteroncology. Accessed July 1, 2026.

APA

VCBacked. (2023). DeuterOncology — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/deuteroncology

Wikipedia (cite web)

{{cite web |title=DeuterOncology — Funding & Investors |url=https://www.vcbacked.co/company/deuteroncology |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 19, 2023.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.